Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas
Clinical trial NCT02341014 · COMPLETED
Trial details
- NCT number
- NCT02341014
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-02
- Primary completion
- 2023-01-11
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.